Beta Bionics

Public

Irvine, CaliforniaHealthcare/Wellnesshttps://www.betabionics.com

Last Round

IPO Announced

Jan 30, 2025

Est. Valuation

$966.2M

Total Funding Raised

$548M

Company Overview

Beta Bionics is a healthcare technology company that develops a bionic pancreas device aimed at alleviating the challenges and expenses associated with diabetes management through an advanced dual-chamber infusion pump that autonomously delivers insulin and glucagon to help patients maintain optimal blood sugar levels.

Sector

Healthcare/Wellness

AI Layer

Application

Keywords

automated insulin delivery (AID) systembionic pancreas for type 1 diabetesinsulin pump without carbohydrate countingautonomous insulin delivery systemadaptive insulin dosing algorithmCGM-integrated insulin pumpdiabetes management technologywearable medical device for diabetesinsulin pump for MDI therapy transitionmobile diabetes data-sharing app

Beta Bionics Comps

Public and private peers based on sector, stage, and business model.

Beta Bionics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Beta Bionics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
IPO Announced	Jan 30, 2025
Series E	Nov 13, 2024
Series D	Aug 30, 2023
Series C	Feb 17, 2022
Series B Extension	Jul 1, 2019
Series B	Jan 8, 2019

View all Funding Rounds

Beta Bionics Investors

Notable investors and investment history

Beta Bionics investors
Investor	Rounds
Soleus Capital	Series D, Series E, Series C
Farallon Capital Management	Series B Extension, Series D, Series C
LifeSci Venture Partners	Series C, Series B
Omega Funds	Series E, Series D
Perceptive Advisors	Series D, Series E, Series B Extension, Series C
Eventide Funds	Series B Extension, Series D, Series E, Series C, Series B
BofA Securities	IPO

View all Investors

Beta Bionics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Beta Bionics Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersIrvine, California

Employee Range383

Year Founded2015

Last FundingJan 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.